1. ACT-20 PHASE 1/2, PROSPECTIVE, INTERNATIONAL MULTI-CENTER STUDY TO ESTABLISH THE SAFETY AND FEASIBILITY OF BLOOD-BRAIN-BARRIER DISRUPTION COMBINED WITH CARBOPLATIN FOR RECURRENT GLIOBLASTOMA; FIRST CLINICAL EXPERIENCE IN JAPAN. (3rd December 2022) Authors: Kijima, Noriyuki; Kanemoto, Manabu; Oshino, Satoru; Tani, Naoki; Hosomi, Koichi; Okita, Yoshiko; Hirayama, Ryuichi; Tachi, Tetsuro; Kuroda, Hideki; Utsuki, Rena; Kagawa, Naoki; Kishima, Haruhiko Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy. Issue 1 (15th November 2022) Authors: Nakagawa, Tomoyoshi; Kijima, Noriyuki; Hasegawa, Kana; Ikeda, Shunya; Yaga, Moto; Wibowo, Tansri; Tachi, Tetsuro; Kuroda, Hideki; Hirayama, Ryuichi; Okita, Yoshiko; Kinoshita, Manabu; Kagawa, Naoki; Kanemura, Yonehiro; Hosen, Naoki; Kishima, Haruhiko Journal: Neuro-oncology advances Issue: Volume 5:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IM-3 IDENTIFICATION OF THERAPEUTIC TARGET ANTIGENS USING PATIENT DERIVED GLIOBLASTOMA AND THEIR APPLICATION TO CAR-T THERAPY. (3rd December 2022) Authors: Kuroda, Hideki; Kijima, Noriyuki; Tachi, Tetsuro; Utsugi, Rena; HIrayama, Ryuichi; Okita, Yoshiko; Kagawa, Maoki; Hosen, Naoki; Kishima, Haruhiko Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IMMU-19. IDENTIFICATION OF TARGET ANTIGENS FOR CHIMERIC ANTIGEN RECEPTOR T- CELL THERAPY AGAINST GLIOBLASTOMA USING A MONOCLONAL ANTIBODY LIBRARY RAISED AGAINST PATIENT-DERIVED TUMOR SPHERES. (14th November 2022) Authors: Kijima, Noriyuki; Nakagawa, Tomoyoshi; Hasegawa, Kana; Ikeda, Shunya; Yaga, Moto; Wibowo, Tansri; Kuroda, Hideki; Hirayama, Ryuichi; Okita, Yoshiko; Tachi, Tetsuro; Kagawa, Naoki; Kanemura, Yonehiro; Hosen, Naoki; Kishima, Haruhiko Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ML-09 DIAGNOSIS AND TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IN HIV POSITIVE PATIENTS. (16th December 2019) Authors: Takano, Koji; Nishimoto, Keisuke; Yamazaki, Hiroki; Murakami, Koki; Tachi, Tetsuro; Kidani, Tomoki; Kanemura, Yonehiro; Nakajima, Shin; Masuda, Tomohito; Kurusu, Tomomi; Hirota, Kazuyuki; Uechi, Takashi; Watanabe, Dai; Nishida, Yasuharu; Uehira, Tomoko; Fujinaka, Toshiyuki Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MNG-3 STRATIFICATION OF TUMOR GROWTH BY RISK FACTORS AND PREDICTED TUMOR VOLUME CURVES FOR SUPRATENTORIAL MENINGIOMAS. (3rd December 2022) Authors: Hirayama, Ryuichi; Yamada, Shuhei; Iwata, Takamitsu; Utsugi, Reina; Tachi, Tetsuro; Kuroda, Hideki; Kijima, Noriyuki; Okita, Yoshiko; Kagawa, Naoki; Kishima, Haruhiko Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NI-3 FEASIBILITY OF MRI PERFUSION IN DISCRIMINATING BETWEEN EDEMA AND INFILTRATIVE AREAS IN THE PERI-GBM NON-CONTRAST T2 WEIGHTED HIGH AREA. (3rd December 2022) Authors: Kuroda, Hideki; Okita, Yoshiko; Arisawa, Atsuko; Utugi, Rena; Tachi, Tetsuro; Hirayama, Ryuichi; Kijima, Noriyuki; Nakamura, Hajime; Kagawa, Naoki; Kishima, Haruhiko Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗